Genel Ürün Özellikleri
| Şartname | Detay / Değer |
| Ürün Adı | Atlas Koroner Stent (Paslanmaz Çelik) |
| Stent Tipi | Balonla Genişletilebilen Koroner Stent |
| Malzeme | 316L Paslanmaz Çelik (Tıbbi Sınıf) |
| Destek Kalınlığı | ~100 μm (tipik) |
| Tasarım | Açık Hücreli veya Hibrit Hücreli tasarım (belirli modele göre değişir) |
| Nominal Basınç (NP) | ~8–9 atm |
| Nominal Patlama Basıncı (RBP) | ~14–16 atm |
| Teslimat Sistemi | Hızlı Değişim (RX) veya Kablo Üzerinden (OTW), genellikle 140 cm şaft uzunluğu |
| Kılavuz Tel Uyumluluğu | 0,014” |
| Endikasyonlar | Koroner arter lezyon iskelesi (BMS veya DES kaplaması için platform olarak kullanılabilir) |
| Kontrendikasyonlar | Balonla genişletilebilen stent için uygun olmayan lezyonlar, ileri derecede kalsifiye damarlar, korunmasız ise sol ana damar hastalığı vb. |
| Kısırlık | Steril (Etilen Oksit) |
| Tek Kullanımlık | Evet |
| Raf ömrü | 2–3 yıl (son paketleme ve varsa kaplamaya bağlı olarak) |
| Çalışma Sıcaklığı | Depolama için önerilen sıcaklık 15–25 °C |
Ayrıntılı Beden Bazlı Sipariş ve Ürün Kodları
| Stent Çapı (mm) | Stent Uzunluğu (mm) | Nominal Basınç (atm) | RBP (atm) | Ürün Kodu |
| 2.00 | 8 | 8 | 14 | ATLS-SS-2.00x08 |
| 2.00 | 12 | 8 | 14 | ATLS-SS-2.00x12 |
| 2.00 | 15 | 8 | 14 | ATLS-SS-2.00x15 |
| 2.00 | 18 | 9 | 16 | ATLS-SS-2.00x18 |
| 2.00 | 24 | 9 | 16 | ATLS-SS-2.00x24 |
| 2.00 | 28 | 9 | 16 | ATLS-SS-2.00x28 |
| 2.00 | 32 | 9 | 16 | ATLS-SS-2.00x32 |
| 2.00 | 38 | 9 | 16 | ATLS-SS-2.00x38 |
| 2.25 | 8 | 8 | 14 | ATLS-SS-2.25x08 |
| 2.25 | 12 | 8 | 14 | ATLS-SS-2.25x12 |
| 2.25 | 15 | 8 | 14 | ATLS-SS-2.25x15 |
| 2.25 | 18 | 9 | 16 | ATLS-SS-2.25x18 |
| 2.25 | 24 | 9 | 16 | ATLS-SS-2.25x24 |
| 2.25 | 28 | 9 | 16 | ATLS-SS-2.25x28 |
| 2.25 | 32 | 9 | 16 | ATLS-SS-2.25x32 |
| 2.25 | 38 | 9 | 16 | ATLS-SS-2.25x38 |
| 2.50 | 8 | 8 | 14 | ATLS-SS-2.50x08 |
| 2.50 | 12 | 8 | 14 | ATLS-SS-2.50x12 |
| 2.50 | 15 | 8 | 14 | ATLS-SS-2.50x15 |
| 2.50 | 18 | 9 | 16 | ATLS-SS-2.50x18 |
| 2.50 | 24 | 9 | 16 | ATLS-SS-2.50x24 |
| 2.50 | 28 | 9 | 16 | ATLS-SS-2.50x28 |
| 2.50 | 32 | 9 | 16 | ATLS-SS-2.50x32 |
| 2.50 | 38 | 9 | 16 | ATLS-SS-2.50x38 |
| 2,75 | 8 | 8 | 14 | ATLS-SS-2.75x08 |
| 2,75 | 12 | 8 | 14 | ATLS-SS-2.75x12 |
| 2,75 | 15 | 8 | 14 | ATLS-SS-2.75x15 |
| 2,75 | 18 | 9 | 16 | ATLS-SS-2.75x18 |
| 2,75 | 24 | 9 | 16 | ATLS-SS-2.75x24 |
| 2,75 | 28 | 9 | 16 | ATLS-SS-2.75x28 |
| 2,75 | 32 | 9 | 16 | ATLS-SS-2.75x32 |
| 2,75 | 38 | 9 | 16 | ATLS-SS-2.75x38 |
| 3.00 | 8 | 8 | 14 | ATLS-SS-3.00x08 |
| 3.00 | 12 | 8 | 14 | ATLS-SS-3.00x12 |
| 3.00 | 15 | 8 | 14 | ATLS-SS-3.00x15 |
| 3.00 | 18 | 9 | 16 | ATLS-SS-3.00x18 |
| 3.00 | 24 | 9 | 16 | ATLS-SS-3.00x24 |
| 3.00 | 28 | 9 | 16 | ATLS-SS-3.00x28 |
| 3.00 | 32 | 9 | 16 | ATLS-SS-3.00x32 |
| 3.00 | 38 | 9 | 16 | ATLS-SS-3.00x38 |
| 3.50 | 8 | 8 | 14 | ATLS-SS-3.50x08 |
| 3.50 | 12 | 8 | 14 | ATLS-SS-3.50x12 |
| 3.50 | 15 | 8 | 14 | ATLS-SS-3.50x15 |
| 3.50 | 18 | 9 | 16 | ATLS-SS-3.50x18 |
| 3.50 | 24 | 9 | 16 | ATLS-SS-3.50x24 |
| 3.50 | 28 | 9 | 16 | ATLS-SS-3.50x28 |
| 3.50 | 32 | 9 | 16 | ATLS-SS-3.50x32 |
| 3.50 | 38 | 9 | 16 | ATLS-SS-3.50x38 |
| 4.00 | 8 | 8 | 14 | ATLS-SS-4.00x08 |
| 4.00 | 12 | 8 | 14 | ATLS-SS-4.00x12 |
| 4.00 | 15 | 8 | 14 | ATLS-SS-4.00x15 |
| 4.00 | 18 | 9 | 16 | ATLS-SS-4.00x18 |
| 4.00 | 24 | 9 | 16 | ATLS-SS-4.00x24 |
| 4.00 | 28 | 9 | 16 | ATLS-SS-4.00x28 |
| 4.00 | 32 | 9 | 16 | ATLS-SS-4.00x32 |
| 4.00 | 38 | 9 | 16 | ATLS-SS-4.00x38 |
The ATLAS Drug Eluting Coronary Stent System SS is a stainless steel (SS) stent platform coated with a sirolimus formulation (1 µg/mm²), designed to prevent restenosis and support durable revascularization in patients with coronary artery disease. By delivering a targeted antiproliferative effect at the lesion site, it is indicated for both de novo coronary lesions and in-stent restenosis (ISR) management, thereby extending its clinical versatility in the percutaneous coronary intervention (PCI) setting.
Stainless Steel Construction
•High Strength-to-Weight Ratio: Enables thinner struts without sacrificing radial force, ensuring ease of deliverability and vessel conformability.
•Proven Biocompatibility: Stainless steel has a long history of safe use in coronary interventions, supporting stable endothelization.
Laser-Cut Stent Design
•Optimized Strut Geometry: Precisely formed lattice structure provides consistent drug distribution and minimal tissue trauma.
•Improved Crossability: The low-profile SS stent tracks smoothly through complex or calcified lesions, reducing the need for extensive lesion preparation.
Sirolimus Drug Coating (1 µg/mm²)
•Targeted Antiproliferation: Gradual drug release inhibits smooth muscle cell proliferation, a primary contributor to in-stent restenosis.
•Enhanced Endothelialization: Balanced drug elution fosters early endothelial coverage, mitigating late stent thrombosis risk.
Pt-Ir Radiopaque Markers
•Fluoroscopic Precision: Platinum-iridium markers at the stent’s extremities promote accurate stent positioning in the coronary vasculature.
•Reduced Geographic Miss: Clear visibility assists operators in precise stent deployment and lesion coverage.
High-Pressure Endurance
Nominal pressure of 10 atm and a rated burst pressure of 20 atm provide interventional cardiologists the latitude to optimize stent expansion and device apposition based on lesion morphology.
